Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Deferred Taxes (2024)

Onconetix (ONCO) has disclosed Deferred Taxes for 1 consecutive years, with -$917998.0 as the latest value for Q4 2024.

  • On a quarterly basis, Deferred Taxes changed N/A to -$917998.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$1.0 million, a N/A change, with the full-year FY2024 number at -$1.0 million, down 8199.7% from a year prior.
  • Deferred Taxes was -$917998.0 for Q4 2024 at Onconetix, down from -$56384.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $50768.0 in Q2 2024 to a low of -$917998.0 in Q4 2024.